Albertella, M. et al. (2008) Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study. Clinical Cancer Research, 14(4), pp. 1096-1104.
Full text not currently available from Enlighten.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Rampling, Professor Roy |
Authors: | Albertella, M., Loadman, P., Jones, P., Phillips, R., Rampling, R., Burnet, N., Alcock, C., Anthoney, A., Vjaters, E., Dunk, C., Harris, P., Wong, A., Lalani, A., and Twelves, C. |
College/School: | College of Medical Veterinary and Life Sciences |
Journal Name: | Clinical Cancer Research |
University Staff: Request a correction | Enlighten Editors: Update this record